Aquestive Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:AQST) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -45.46 M-32.98 M-9.79 M-6.38 M-35.76 M-52.43 M -43.84 M Cash from investing activities -517 K-913 K-2.52 M-995 K-159 K-562 K -479 K Cash from financing activities 28.46 M30.11 M11.56 M3.97 M83.59 M102.62 M 86.39 M Free cash flow -45.46 M-32.98 M-9.79 M-6.38 M-35.76 M-52.99 M -44.32 M

News

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates

Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should Know

Will Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should Know

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST)

Aquestive Therapeutics chief people officer Boyd sells $124k in stock

Aquestive Therapeutics CEO Barber sells $753,965 in stock

Aquestive Therapeutics SVP Cioffi sells $105k in shares

Aquestive therapeutics chief legal officer Braender sells $167k in stock

Aquestive Therapeutics: With Some Hiccups, Anaphylm Is Closer To FDA Approval